S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
ASX:CYC

Cyclopharm Limited (CYC.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$1.36
MA: A$1.36
A$1.36
52-Week Range N/A
Volume10,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.40%
BetaN/A
Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. It offers diagnostic equipment and consumables, which are used by physicians in the detection of pulmonary embolism. The company also provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments in hospitals. The company has research collaboration agreement with McMasters University and others to understand the short-term and long-term effects of COVID-19 on lung ventilation and perfusion injury. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

MarketRank

Overall MarketRank

0.79 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 9541 0411
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$16.28 million
Book ValueA$0.21 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive CYC News and Ratings via Email

Sign-up to receive the latest news and ratings for CYC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cyclopharm Limited (CYC.AX) (ASX:CYC) Frequently Asked Questions

What stocks does MarketBeat like better than Cyclopharm Limited (CYC.AX)?

Wall Street analysts have given Cyclopharm Limited (CYC.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cyclopharm Limited (CYC.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How often does Cyclopharm Limited (CYC.AX) pay dividends? What is the dividend yield for Cyclopharm Limited (CYC.AX)?

Cyclopharm Limited (CYC.AX) announced a Interim dividend on Wednesday, August 26th. Shareholders of record on Monday, September 14th will be paid a dividend of 0.005 per share on Monday, September 14th. This represents a yield of 0.37%. The ex-dividend date is Friday, September 4th.
View Cyclopharm Limited (CYC.AX)'s dividend history
.

Is Cyclopharm Limited (CYC.AX) a good dividend stock?

Cyclopharm Limited (CYC.AX) pays an annual dividend of A$0.01 per share and currently has a dividend yield of 0.40%.
View Cyclopharm Limited (CYC.AX)'s dividend history.

Who are some of Cyclopharm Limited (CYC.AX)'s key competitors?

Who are Cyclopharm Limited (CYC.AX)'s key executives?

Cyclopharm Limited (CYC.AX)'s management team includes the following people:
  • Mr. James S. McBrayer F.A.C.I.D., BSPharm, GDM, FAICD, AIM, CEO, MD, Company Sec. & Director (Age 55, Pay $433.74k)
  • Mr. Mathew Farag, Chief Operating Officer
  • Mr. Graham N. Phillips, Fin. Mang.
  • Dr. Mark Doverty, Global Head of Regulatory Compliance & Clinical Research
  • Ms. Sally-Ann Cornelius, Head of Sales
  • Ms. Niamh McAree, Head of Quality and Regulatory
  • Mr. Chris Quinn, Head of Service
  • Ms. Sui Ling Cheah, Financial Controller (Age 50)
  • Mr. Lynn McLauchlin, Gen. Mang. of Canada
  • Mr. Bjorn Altmann, Gen. Mang. of Europe

What is Cyclopharm Limited (CYC.AX)'s stock symbol?

Cyclopharm Limited (CYC.AX) trades on the ASX under the ticker symbol "CYC."

How big of a company is Cyclopharm Limited (CYC.AX)?

Cyclopharm Limited (CYC.AX) has a market capitalization of $0.00 and generates $16.28 million in revenue each year. Cyclopharm Limited (CYC.AX) employs 37 workers across the globe.

What is Cyclopharm Limited (CYC.AX)'s official website?

The official website for Cyclopharm Limited (CYC.AX) is www.cyclopharm.com.au.

How can I contact Cyclopharm Limited (CYC.AX)?

The company can be reached via phone at 61 2 9541 0411.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.